Video Gallery

Opening Remarks
	Opening Remarks Dr. Wen-Chien Chou

MPN: What's New?
	MPN Updates and the Evolution of the Disease Dr. Ruben Mesa
	Clinical Relevance of Mutation Allele Burden in MPN Dr. Hsin-An Hou
	A Paradigm Shift in The Diagnosis and Treatment of MPNs, Sooner Better than Later? Dr. Hans K Hasselbalch

Interferon Treatment in PV: Revolution
	Six-year Results of the PROUD/CONTI-PV Study Dr. Jean-Jacques Kiladjian
	Efficacy and Safety of Ropeginterferon Alfa-2b Treatment in Japanese Patients with PV Dr. Keita Kirito
	Molecular Response of Ropeginterferon Alfa-2b in Korea Patients with PV Dr. Sung-Eun Lee

Clinical Diagnosis and Characteristics of MPN
	Polycythemia Vera 2023. Can We Improve Outcomes? Dr. Josef Prchal
	Clinical Characteristics of Japanese Patients with PV/ET Dr. Katsuto Takenaka
	Clinicophenotype of Essential Thrombocythemia in Asian Patients Dr. Chin-Hin Ng

Unmet Needs and Advances in MPN
	Intervention in Prefibrotic and Early Overt Myelofibrosis Dr. Abdulraheem Yacoub
	Ropeginterferon Alfa-2b in Early Myelofibrosis Dr. Harry Gill
	Long-Acting Interferon and Ropeginterferon: Lessons from Finite-Period Therapy of Chronic Viral Hepatitis to Long-term Therapy for MPN Dr. Pei-Jer Chen

Panel Discussion

Panel Discussion

Dr. Jean-Jacques Kiladjian & Dr. Hwei-Fang Tien

Closing Remaks

Closing Remarks

Dr. Wen-Chien Chou